Intrinsiqq
Aibotics Inc. logo

Aibotics Inc. Financials

AIBT

Compare

All currency values in $ millions unless otherwise noted

Scroll

Showing 6 of 9 available years
Income Statement
TTM
~1.8:1 split
DEC 2025
~12.2:1 split
DEC 2024
~2.7:1 split
DEC 2023
DEC 2022
DEC 2021
Revenues
Revenue$0$0$0–––
Gross Profit$0$0$0–––
General & Administrative$2$2$2$1$2$5
Total Operating Expenses$2$2$2$1$2$5
Operating Income-$2-$2-$2-$1-$2-$5
Non-Operating
Net Interest Expense-$0-$0-$0-$1-$1-$0
Other Non-Operating Income (Expense)-$0-$0$0$0-$0-$0
EBT (Earnings Before Tax)-$2-$2-$2-$1-$3-$5
Income Tax Expense$0$0$0$0$0$0
Net Income
Net Income-$2-$2-$2-$1-$3-$5
Per Share Data
Revenue Per Share$0.00$0.00$0.00–––
EPS (Basic)$0.02-$0.00-$0.05-$0.08-$0.18-$0.38
EPS (Diluted)$0.02-$0.00-$0.05-$0.08-$0.18-$0.38
Weighted Avg Shares (Basic)–––––13.4M
Weighted Avg Shares (Diluted)–––––13.4M
Shares Outstanding890.2M486.9M40.0M14.9M14.9M13.4M

Aibotics (AIBT) financials: revenue, profit and margins

Aibotics (AIBT) generated about $0.00 in revenue and -$2 million in net income (a -101,500.3% net margin) over the trailing twelve months. Figures are from SEC filings; this is analysis, not investment advice.

Frequently asked

What is Aibotics's (AIBT) revenue?+

Aibotics generated about $0.00 in revenue over the trailing twelve months. Revenue is the top line, before any costs; what matters for value is how much of it survives to free cash flow. The full income statement, balance sheet and cash-flow statement are on this tab.

Is Aibotics profitable?+

Aibotics reported about -$2 million in net loss over the trailing twelve months, a net margin of roughly -101,500.3%. Net income is the bottom line after all costs, interest and taxes. Compare it to free cash flow on this tab, since reported profit and actual cash generated can diverge.

What are Aibotics's profit margins?+

Aibotics runs a gross margin of about 100.0%, an operating margin of about -84,501.7%, a net margin of about -101,500.3%. Margins show how much of each sales dollar a company keeps at each stage. Stable or rising margins usually signal pricing power and cost discipline; falling margins are worth investigating. See the multi-year trend on this tab.

How the market compares: How many US companies are profitable

SourceFinancial statements computed from the 10-Q filed 20 Nov 2026, covering the period ending 30 Sept 2026, as reported to the SEC. Data last refreshed 20 Nov 2026. How this is calculated.

Fiscal year ends Dec.

Peers

Medicinal Chemicals & Botanical Products · Pick stocks to compare with AIBT

CompareIntrinsic value
CHUCCharlie's Holdings Inc.
$0.09-0.58%10
USNAUsana Health Sciences, Inc.
$13.13-0.23%35
CBDYTarget Group Inc.
$0.00+22.22%8
MEHAFunctional Brands Inc.
$0.00+20.00%0
LEEEFLeef Brands Inc.
$0.14+0.28%26
HYEXHealthy Extracts Inc.
$1.29-4.53%58
ADIAAdia Nutrition Inc.
$0.12+0.00%43
FTLFFitLife Brands, Inc.
$6.32-5.67%74

Spot a number that looks wrong? Check it in AIBT's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing AIBT

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.